Direxion Daily SandP Biotech Bear 3X ETF (LABD) |
| 13.4899 -1.22 (-8.29%) 04-14 12:52 |
| Open: | 14.37 |
| High: | 14.38 |
| Low: | 13.255 |
| Volume: | 8,254,012 |
| Market Cap: | 31(M) |
| PE Ratio: | 0 |
| Exchange: | New York Stock Exchange Arca |
| Industry: | Asset Management - Leveraged |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 21.53 |
| Resistance 1: | 18.37 |
| Pivot price: | 16.89 |
| Support 1: | 13.26 |
| Support 2: | 11.03 |
| 52w High: | 111.5 |
| 52w Low: | 13.255 |
The Direxion Daily S&P Biotech Bull and Bear 3X ETFs seek daily investment results, before fees and expenses, of 300%, or 300% of the inverse (or opposite), of the performance of the S&P Biotechnology Select Industry Index. There is no guarantee the funds will achieve their stated investment objectives.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Mon, 13 Apr 2026
Direxion Daily S&P Biotech Bear 3X Shares declares quarterly distribution of $0.0853 - MSN
Tue, 10 Feb 2026
5 Small-cap Biotech ETFs to Watch - Investing News Network
Mon, 02 Feb 2026
LABD: ETF To Benefit From Downturns In The Biotech Industry (NYSEARCA:LABD) - Seeking Alpha
Thu, 22 Jan 2026
LABD Forecast — Price Prediction for 2026. Should I Buy LABD? - Intellectia AI
Wed, 14 May 2025
Top Performing Leveraged/Inverse ETFs: 05/11/2025 - ETF Database
Thu, 10 Apr 2025
Top Performing Leveraged/Inverse ETFs: 04/06/2025 - ETF Database
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
